Evidence map›Paper›PMID 38647675›Full record

ReviewArchives of microbiology2024

Stilbenes: a journey from folklore to pharmaceutical innovation.

Gursharan Kaur, Rajinder Kaur, Gurleen Kaur Sodhi, Nancy George, Santosh Kumar Rath, Harleen Kaur Walia, Vagish Dwibedi, Sanjai Saxena

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Improved Bioavailability of Stilbenes fromMolecules (Basel, Switzerland) · 2025
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gursharan KaurUniversity Institute of Biotechnology, Chandigarh University, Mohali, 140413, Punjab, India.
Rajinder KaurDepartment of Plant Sciences, University of Idaho Moscow, Idaho, ID, 83844, USA.
Gurleen Kaur SodhiDepartment of Biotechnology, Thapar Institute of Engineering and Technology Patiala, Patiala, Punjab, 147004, India.
Nancy GeorgeUniversity Institute of Biotechnology, Chandigarh University, Mohali, 140413, Punjab, India.
Santosh Kumar RathSchool of Pharmaceuticals and Population Health Informatics, Faculty of Pharmacy, DIT University, Dehradun, Uttarakhand, 248009, India.
Harleen Kaur WaliaDepartment of Biotechnology, Thapar Institute of Engineering and Technology Patiala, Patiala, Punjab, 147004, India.
Vagish DwibediUniversity Institute of Biotechnology, Chandigarh University, Mohali, 140413, Punjab, India. vagishdwibedi@gmail.com.
Sanjai SaxenaDepartment of Biotechnology, Thapar Institute of Engineering and Technology Patiala, Patiala, Punjab, 147004, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In modern times, medicine is predominantly based on evidence-based practices, whereas in ancient times, indigenous people relied on plant-based medicines with factual evidence documented in ancient books or folklore that demonstrated their effectiveness against specific infections. Plants and microbes account for 70% of drugs approved by the USFDA (U.S. Food and Drug Administration). Stilbenes, polyphenolic compounds synthesized by plants under stress conditions, have garnered significant attention for their therapeutic potential, bridging ancient wisdom with modern healthcare. Resveratrol, the most studied stilbene, initially discovered in grapes, red wine, peanuts, and blueberries, exhibits diverse pharmacological properties, including cardiovascular protection, antioxidant effects, anticancer activity, and neuroprotection. Traditional remedies, documented in ancient texts like the Ayurvedic Charak Samhita, foreshadowed the medicinal properties of stilbenes long before their modern scientific validation. Today, stilbenes are integral to the booming wellness and health supplement market, with resveratrol alone projected to reach a market value of 90 million US$ by 2025. However, challenges in stilbene production persist due to limited natural sources and costly extraction methods. Bioprospecting efforts reveal promising candidates for stilbene production, particularly endophytic fungi, which demonstrate high-yield capabilities and genetic modifiability. However, the identification of optimal strains and fermentation processes remains a critical consideration. The current review emphasizes the knowledge of the medicinal properties of Stilbenes (i.e., cardiovascular, antioxidant, anticancer, anti-inflammatory, etc.) isolated from plant and microbial sources, while also discussing strategies for their commercial production and future research directions. This also includes examples of novel stilbenes compounds reported from plant and endophytic fungi.

Indexed as

ResveratrolStilbenesAntioxidantsEndophytesFungiHumansMedicine, TraditionalPlantsAntioxidantsResveratrolStilbenesEndophytic fungiMedicinal propertiesResveratrolStilbenes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.